$HQY
HEALTHEQUITY, INC.

2022 Q2 Form 10-Q Financial Statement

#000142833622000018 Filed on June 08, 2022

View on sec.gov

Income Statement

Concept 2022 Q2 2022 Q1 2021 Q2
Revenue $205.7M $203.3M $184.2M
YoY Change 11.66% 8.02% -3.06%
Cost Of Revenue $94.51M $98.00M $81.09M
YoY Change 16.55% 12.25% -1.04%
Gross Profit $111.2M $105.3M $103.1M
YoY Change 7.81% 4.36% -4.59%
Gross Profit Margin 54.05% 51.8% 55.98%
Selling, General & Admin $40.29M $37.19M $34.77M
YoY Change 15.86% 2.18% 14.19%
% of Gross Profit 36.24% 35.32% 33.72%
Research & Development $45.18M $45.93M $35.47M
YoY Change 27.39% 42.19% 14.13%
% of Gross Profit 40.64% 43.62% 34.4%
Depreciation & Amortization $39.49M $38.82M $31.77M
YoY Change 24.29% 27.71% 15.49%
% of Gross Profit 35.52% 36.87% 30.81%
Operating Expenses $118.5M $106.2M $98.86M
YoY Change 19.82% 20.92% 6.3%
Operating Profit -$7.289M -$867.0K $4.253M
YoY Change -271.38% -106.62% -71.78%
Interest Expense $10.46M -$10.65M $6.689M
YoY Change 56.39% 61.38% -45.45%
% of Operating Profit 157.28%
Other Income/Expense, Net -$10.76M $51.00K -$10.32M
YoY Change 4.29% -99.35% -20.79%
Pretax Income -$18.05M -$43.77M -$6.066M
YoY Change 197.58% 3266.54% -396.77%
Income Tax -$4.400M -$10.95M -$3.500M
% Of Pretax Income
Net Earnings -$13.64M -$32.82M -$2.615M
YoY Change 421.57% -707.74% -243.21%
Net Earnings / Revenue -6.63% -16.14% -1.42%
Basic Earnings Per Share -$0.16 -$0.03
Diluted Earnings Per Share -$0.16 -$392.0K -$0.03
COMMON SHARES
Basic Shares Outstanding 84.02M shares 83.82M shares 81.75M shares
Diluted Shares Outstanding 84.02M shares 81.75M shares

Balance Sheet

Concept 2022 Q2 2022 Q1 2021 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $161.2M $225.4M $736.8M
YoY Change -78.11% -31.44% 330.61%
Cash & Equivalents $161.2M $225.4M $736.8M
Short-Term Investments
Other Short-Term Assets $31.67M $38.50M $53.87M
YoY Change -41.2% -34.32% 25.57%
Inventory
Prepaid Expenses
Receivables $86.00M $87.43M $74.47M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $278.9M $351.3M $865.1M
YoY Change -67.76% -23.65% 204.85%
LONG-TERM ASSETS
Property, Plant & Equipment $21.00M $23.37M $27.48M
YoY Change -23.57% -19.7% -23.29%
Goodwill $1.646B $1.646B $1.364B
YoY Change 20.7% 24.01% 2.32%
Intangibles $1.008B $973.1M $780.8M
YoY Change 29.08% 26.88% 0.43%
Long-Term Investments
YoY Change
Other Assets $48.84M $49.81M $38.78M
YoY Change 25.95% 33.1% 10.26%
Total Long-Term Assets $2.786B $2.756B $2.297B
YoY Change 21.31% 22.47% 0.79%
TOTAL ASSETS
Total Short-Term Assets $278.9M $351.3M $865.1M
Total Long-Term Assets $2.786B $2.756B $2.297B
Total Assets $3.065B $3.107B $3.162B
YoY Change -3.06% 14.64% 23.39%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $13.66M $27.54M $9.636M
YoY Change 41.77% 1606.38% 31.32%
Accrued Expenses $47.84M $57.59M $73.45M
YoY Change -34.86% -24.11% 83.68%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $10.94M $8.750M $62.50M
YoY Change -82.5% -86.0% 33.33%
Total Short-Term Liabilities $117.7M $153.2M $192.3M
YoY Change -38.82% -25.17% 42.87%
LONG-TERM LIABILITIES
Long-Term Debt $918.5M $922.1M $909.8M
YoY Change 0.96% -0.23% -22.05%
Other Long-Term Liabilities $13.92M $14.19M $14.81M
YoY Change -6.02% 61.05% 291.51%
Total Long-Term Liabilities $1.092B $1.101B $1.121B
YoY Change -2.6% -2.27% -19.17%
TOTAL LIABILITIES
Total Short-Term Liabilities $117.7M $153.2M $192.3M
Total Long-Term Liabilities $1.092B $1.101B $1.121B
Total Liabilities $1.210B $1.255B $1.314B
YoY Change -7.9% -5.79% -13.68%
SHAREHOLDERS EQUITY
Retained Earnings $162.4M $176.1M $217.7M
YoY Change -25.4% -20.1% 2.06%
Common Stock $8.000K $8.000K $8.000K
YoY Change 0.0% 0.0% 14.29%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.855B $1.853B $1.848B
YoY Change
Total Liabilities & Shareholders Equity $3.065B $3.107B $3.162B
YoY Change -3.06% 14.64% 23.39%

Cashflow Statement

Concept 2022 Q2 2022 Q1 2021 Q2
OPERATING ACTIVITIES
Net Income -$13.64M -$32.82M -$2.615M
YoY Change 421.57% -707.74% -243.21%
Depreciation, Depletion And Amortization $39.49M $38.82M $31.77M
YoY Change 24.29% 27.71% 15.49%
Cash From Operating Activities $7.077M $50.56M $30.92M
YoY Change -77.11% -16.98% 105.76%
INVESTING ACTIVITIES
Capital Expenditures $1.155M -$16.30M $2.490M
YoY Change -53.61% -19.7% -66.85%
Acquisitions $0.00 $49.53M
YoY Change -100.0%
Other Investing Activities $0.00 -$455.0M -$49.53M
YoY Change -100.0%
Cash From Investing Activities -$74.20M -$471.3M -$67.80M
YoY Change 9.44% 2221.68% 168.05%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00 $456.6M
YoY Change -100.0%
Debt Paid & Issued, Net $2.187M $15.63M
YoY Change -86.0% 100.01%
Cash From Financing Activities $2.959M -2.971M $444.9M
YoY Change -99.33% -73.47% -4391.88%
NET CHANGE
Cash From Operating Activities $7.077M 50.56M $30.92M
Cash From Investing Activities -$74.20M -471.3M -$67.80M
Cash From Financing Activities $2.959M -2.971M $444.9M
Net Change In Cash -$64.17M -423.7M $408.0M
YoY Change -115.73% -1541.21% -2077.27%
FREE CASH FLOW
Cash From Operating Activities $7.077M $50.56M $30.92M
Capital Expenditures $1.155M -$16.30M $2.490M
Free Cash Flow $5.922M $66.86M $28.43M
YoY Change -79.17% -17.66% 278.28%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q2 dei Entity Central Index Key
EntityCentralIndexKey
0001428336
CY2022Q2 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--01-31
CY2022Q2 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q2 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2022Q2 dei Amendment Flag
AmendmentFlag
false
CY2022Q2 dei Document Type
DocumentType
10-Q
CY2022Q2 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2022Q2 dei Document Period End Date
DocumentPeriodEndDate
2022-04-30
CY2022Q2 dei Document Transition Report
DocumentTransitionReport
false
CY2022Q2 dei Entity File Number
EntityFileNumber
001-36568
CY2022Q2 dei Entity Registrant Name
EntityRegistrantName
HEALTHEQUITY, INC.
CY2022Q2 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022Q2 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
52-2383166
CY2022Q2 dei Entity Address Address Line1
EntityAddressAddressLine1
15 West Scenic Pointe Drive
CY2022Q2 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 100
CY2022Q2 dei Entity Address City Or Town
EntityAddressCityOrTown
Draper,
CY2022Q2 dei Entity Address State Or Province
EntityAddressStateOrProvince
UT
CY2022Q2 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
84020
CY2022Q2 dei City Area Code
CityAreaCode
801
CY2022Q2 dei Local Phone Number
LocalPhoneNumber
727-1000
CY2022Q2 dei Security12b Title
Security12bTitle
Common stock, par value $0.0001 per share
CY2022Q2 dei Trading Symbol
TradingSymbol
HQY
CY2022Q2 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022Q2 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022Q2 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q2 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2022Q2 dei Entity Small Business
EntitySmallBusiness
false
CY2022Q2 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022Q2 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
84367663 shares
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
161247000 USD
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
225414000 USD
CY2022Q2 us-gaap Assets Current
AssetsCurrent
278923000 USD
CY2022Q1 us-gaap Assets Current
AssetsCurrent
351337000 USD
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
21003000 USD
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
23372000 USD
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
6542000 USD
CY2022Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
6228000 USD
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
86003000 USD
CY2022Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
87428000 USD
CY2022Q2 us-gaap Other Assets Current
OtherAssetsCurrent
31673000 USD
CY2022Q1 us-gaap Other Assets Current
OtherAssetsCurrent
38495000 USD
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
62599000 USD
CY2022Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
63613000 USD
CY2022Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1007864000 USD
CY2022Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
973137000 USD
CY2022Q2 us-gaap Goodwill
Goodwill
1645836000 USD
CY2022Q1 us-gaap Goodwill
Goodwill
1645836000 USD
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
47840000 USD
CY2022Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
57589000 USD
CY2022Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
918514000 USD
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
48842000 USD
CY2022Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
49807000 USD
CY2022Q2 us-gaap Assets
Assets
3065067000 USD
CY2022Q1 us-gaap Assets
Assets
3107102000 USD
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
13661000 USD
CY2022Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
27541000 USD
CY2022Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
33405000 USD
CY2022Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
47136000 USD
CY2022Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
10938000 USD
CY2022Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
8750000 USD
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
11807000 USD
CY2022Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
12171000 USD
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
117651000 USD
CY2022Q1 us-gaap Liabilities Current
LiabilitiesCurrent
153187000 USD
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
64344000 USD
CY2022Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
922077000 USD
CY2022Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
65232000 USD
CY2022Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
13919000 USD
CY2022Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
14185000 USD
CY2022Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
95376000 USD
CY2022Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
99846000 USD
CY2022Q2 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1092153000 USD
CY2022Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1101340000 USD
CY2022Q2 us-gaap Liabilities
Liabilities
1209804000 USD
CY2022Q1 us-gaap Liabilities
Liabilities
1254527000 USD
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2022Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2022Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2022Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
900000000 shares
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
900000000 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
84365000 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
84365000 shares
CY2022Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
83780000 shares
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
83780000 shares
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
8000 USD
CY2022Q1 us-gaap Common Stock Value
CommonStockValue
8000 USD
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1692835000 USD
CY2022Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1676508000 USD
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
162420000 USD
CY2022Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
176059000 USD
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
1855263000 USD
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
1852575000 USD
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3065067000 USD
CY2022Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3107102000 USD
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
205679000 USD
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
184202000 USD
CY2022Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
94506000 USD
CY2021Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
81086000 USD
CY2022Q2 us-gaap Gross Profit
GrossProfit
111173000 USD
CY2021Q2 us-gaap Gross Profit
GrossProfit
103116000 USD
CY2022Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
16560000 USD
CY2022Q2 us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
9294000 USD
CY2021Q2 us-gaap Business Combination Integration Related Costs
BusinessCombinationIntegrationRelatedCosts
8807000 USD
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
118462000 USD
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
98863000 USD
CY2021Q2 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
14086000 USD
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
45183000 USD
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
35469000 USD
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
23727000 USD
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
20687000 USD
CY2022Q2 hqy Amortization Of Acquired Intangible
AmortizationOfAcquiredIntangible
23698000 USD
CY2021Q2 hqy Amortization Of Acquired Intangible
AmortizationOfAcquiredIntangible
19814000 USD
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-7289000 USD
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
4253000 USD
CY2022Q2 us-gaap Interest Expense
InterestExpense
10461000 USD
CY2021Q2 us-gaap Interest Expense
InterestExpense
6689000 USD
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-301000 USD
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3630000 USD
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-10762000 USD
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-10319000 USD
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-18051000 USD
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6066000 USD
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4412000 USD
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3451000 USD
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-13639000 USD
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-13639000 USD
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2615000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-2615000 USD
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.16
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.16
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
84022000 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
81747000 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
84022000 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
81747000 shares
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
1852575000 USD
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
1378728000 USD
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
1855263000 USD
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
1848270000 USD
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-13639000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-2615000 USD
CY2022Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
39486000 USD
CY2021Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
31768000 USD
CY2022Q2 us-gaap Share Based Compensation
ShareBasedCompensation
13986000 USD
CY2021Q2 us-gaap Share Based Compensation
ShareBasedCompensation
12799000 USD
CY2022Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
812000 USD
CY2021Q2 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1228000 USD
CY2022Q2 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
0 USD
CY2021Q2 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-893000 USD
CY2022Q2 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-4470000 USD
CY2021Q2 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
3243000 USD
CY2022Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1425000 USD
CY2021Q2 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
475000 USD
CY2022Q2 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-7317000 USD
CY2021Q2 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-2249000 USD
CY2022Q2 hqy Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
-2034000 USD
CY2021Q2 hqy Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
-3369000 USD
CY2022Q2 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-13731000 USD
CY2021Q2 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-17748000 USD
CY2022Q2 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-24056000 USD
CY2021Q2 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-381000 USD
CY2022Q2 hqy Increase Decrease In Operating Lease Liability Noncurrent
IncreaseDecreaseInOperatingLeaseLiabilityNoncurrent
-1821000 USD
CY2021Q2 hqy Increase Decrease In Operating Lease Liability Noncurrent
IncreaseDecreaseInOperatingLeaseLiabilityNoncurrent
-2308000 USD
CY2022Q2 us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
-266000 USD
CY2021Q2 us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
-1104000 USD
CY2022Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
7077000 USD
CY2021Q2 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
30918000 USD
CY2022Q2 us-gaap Payments For Software
PaymentsForSoftware
13635000 USD
CY2021Q2 us-gaap Payments For Software
PaymentsForSoftware
15469000 USD
CY2022Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1155000 USD
CY2021Q2 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2490000 USD
CY2022Q2 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
59413000 USD
CY2021Q2 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
309000 USD
CY2022Q2 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
CY2021Q2 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
49533000 USD
CY2022Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-74203000 USD
CY2021Q2 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-67801000 USD
CY2022Q2 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
2187000 USD
CY2021Q2 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
15625000 USD
CY2022Q2 hqy Payments To Settle Client Held Funds
PaymentsToSettleClientHeldFunds
-2335000 USD
CY2021Q2 hqy Payments To Settle Client Held Funds
PaymentsToSettleClientHeldFunds
353000 USD
CY2022Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2811000 USD
CY2021Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4189000 USD
CY2022Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
CY2021Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
456642000 USD
CY2022Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2959000 USD
CY2021Q2 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
444853000 USD
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-64167000 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
407970000 USD
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
225414000 USD
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
328803000 USD
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
161247000 USD
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
736773000 USD
CY2022Q2 us-gaap Interest Paid Net
InterestPaidNet
15496000 USD
CY2021Q2 us-gaap Interest Paid Net
InterestPaidNet
4988000 USD
CY2022Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
55000 USD
CY2021Q2 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-4852000 USD
CY2022Q2 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1165000 USD
CY2021Q2 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
765000 USD
CY2022Q2 us-gaap Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
0 USD
CY2021Q2 us-gaap Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1
NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1
8147000 USD
CY2022Q2 hqy Exerciseof Stock Options Receivable
ExerciseofStockOptionsReceivable
0 USD
CY2021Q2 hqy Exerciseof Stock Options Receivable
ExerciseofStockOptionsReceivable
5000 USD
CY2022Q2 us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
Certain reclassifications have been made to prior year amounts to conform to the current year presentation.
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
84022000 shares
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-13639000 USD
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-2615000 USD
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
84022000 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
81747000 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
84022000 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
81747000 shares
CY2022Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2021Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
81747000 shares
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.16
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.16
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2000000 shares
CY2021Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1900000 shares
CY2022Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
59249000 USD
CY2022Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
58972000 USD
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
38246000 USD
CY2022Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
35600000 USD
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
21003000 USD
CY2022Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
23372000 USD
CY2022Q2 us-gaap Depreciation
Depreciation
3300000 USD
CY2021Q2 us-gaap Depreciation
Depreciation
3900000 USD
CY2022Q2 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
10000000 USD
CY2022Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
10500000 USD
CY2022Q2 us-gaap Revenue Remaining Performance Obligation Percentage
RevenueRemainingPerformanceObligationPercentage
0.50
CY2022Q2 us-gaap Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1
RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
P12M
CY2022Q2 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
1200000 USD
CY2022Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
2859000 USD
CY2021Q2 us-gaap Operating Lease Expense
OperatingLeaseExpense
4313000 USD
CY2022Q2 us-gaap Sublease Income
SubleaseIncome
495000 USD
CY2021Q2 us-gaap Sublease Income
SubleaseIncome
450000 USD
CY2022Q2 us-gaap Lease Cost
LeaseCost
2364000 USD
CY2022Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
6000 USD
CY2021Q2 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
5939000 USD
CY2022Q2 hqy Other Nonoperating Income Expense Miscellaneous
OtherNonoperatingIncomeExpenseMiscellaneous
-347000 USD
CY2021Q2 us-gaap Lease Cost
LeaseCost
3863000 USD
CY2022Q2 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
52000 USD
CY2021Q2 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
408000 USD
CY2021Q2 hqy Other Nonoperating Income Expense Miscellaneous
OtherNonoperatingIncomeExpenseMiscellaneous
1901000 USD
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-301000 USD
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-3630000 USD
CY2022Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
3098000 USD
CY2021Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
3635000 USD
CY2022Q2 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1020000 USD
CY2021Q2 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 USD
CY2018Q2 hqy Loss Contingency Number Of Lawsuits
LossContingencyNumberOfLawsuits
2 lawsuit
CY2022Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1360292000 USD
CY2022Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1289854000 USD
CY2022Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
352428000 USD
CY2022Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
316717000 USD
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1007864000 USD
CY2022Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
973137000 USD
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
36200000 USD
CY2021Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
27900000 USD
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-3500000 USD
CY2018Q3 hqy Loss Contingency Number Of Lawsuits
LossContingencyNumberOfLawsuits
2 lawsuit
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-4400000 USD
CY2022Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.244
CY2021Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.571
CY2022Q2 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
-0.043
CY2021Q2 us-gaap Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent
EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent
-0.332
CY2022Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
11800000 USD
CY2022Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
11700000 USD
CY2022Q2 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
8500000 USD
CY2022Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
947813000 USD
CY2022Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
950000000 USD
CY2022Q2 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
18361000 USD
CY2022Q1 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
19173000 USD
CY2022Q2 us-gaap Long Term Debt
LongTermDebt
929452000 USD
CY2022Q1 us-gaap Long Term Debt
LongTermDebt
930827000 USD
CY2022Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
10938000 USD
CY2022Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
8750000 USD
CY2022Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
918514000 USD
CY2022Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
922077000 USD
CY2022Q2 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
18400000 USD
CY2022Q1 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
19200000 USD
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
13986000 USD
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
13141000 USD
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1232000 shares
CY2022Q1 hqy Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit Outstanding
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitOutstanding
1.25
CY2022Q1 hqy Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit Outstanding
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitOutstanding
82.39
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
35.64
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y2M12D
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
25719000 USD
CY2022Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
62000 shares
CY2022Q2 hqy Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit Exercised
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitExercised
1.25
CY2022Q2 hqy Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit Exercised
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitExercised
51.44
CY2022Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
38.18
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
33052000 USD
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
2000 shares
CY2022Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
28.69
CY2022Q2 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
28.69
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1168000 shares
CY2022Q2 hqy Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit Outstanding
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimitOutstanding
1.25
CY2022Q2 hqy Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit Outstanding
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimitOutstanding
82.39
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
35.52
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y10M24D
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
33070000 USD
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
1168000 shares
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
35.52
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P3Y10M24D
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
33070000 USD
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
1129000 shares
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
34.24
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y9M18D

Files In Submission

Name View Source Status
0001428336-22-000018-index-headers.html Edgar Link pending
0001428336-22-000018-index.html Edgar Link pending
0001428336-22-000018.txt Edgar Link pending
0001428336-22-000018-xbrl.zip Edgar Link pending
exhibit311-ceo302xfy23q1.htm Edgar Link pending
exhibit312-cfo302xfy23q1.htm Edgar Link pending
exhibit321-ceo906xfy23q1.htm Edgar Link pending
exhibit322-cfo906xfy23q1.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
hqy-20220430.htm Edgar Link pending
hqy-20220430.xsd Edgar Link pending
hqy-20220430_cal.xml Edgar Link unprocessable
hqy-20220430_def.xml Edgar Link unprocessable
hqy-20220430_htm.xml Edgar Link completed
hqy-20220430_lab.xml Edgar Link unprocessable
hqy-20220430_pre.xml Edgar Link unprocessable
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending